Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$856M |
| 2 |
Meta Platforms (Facebook)
META
|
+$647M |
| 3 |
NVIDIA
NVDA
|
+$615M |
| 4 |
Berkshire Hathaway Class A
BRK.A
|
+$304M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.03B |
| 2 |
UnitedHealth
UNH
|
+$686M |
| 3 |
Tesla
TSLA
|
+$387M |
| 4 |
Abbott
ABT
|
+$380M |
| 5 |
Chevron
CVX
|
+$328M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.26% |
| 2 | Healthcare | 16.96% |
| 3 | Consumer Discretionary | 12.82% |
| 4 | Consumer Staples | 9.14% |
| 5 | Industrials | 9.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
SBA Communications
SBAC
$19.3B
| $78.9M | 0.11% |
340,249
+57,032
| +20% | +$13.6M |
|
202
Nutrien
NTR
$32.1B
| $78M | 0.11% |
1,321,595
+639,410
| +94% | +$40.7M |
|
203
Bristol-Myers Squibb
BMY
$130B
| $77.3M | 0.11% |
1,209,400
+65,100
| +6% | +$4.37M |
|
204
Nokia
NOK
$52.7B
| $77.1M | 0.11% |
18,531,480
-10,054,700
| -35% | -$42.5M |
|
205
Sherwin-Williams
SHW
$88.5B
| $77.1M | 0.11% |
290,300
-255,000
| -47% | -$60M |
|
206
TJX Companies
TJX
$172B
| $76.3M | 0.11% |
900,300
-1,141,400
| -56% | -$90M |
|
207
Usana Health Sciences
USNA
$254M
| $76.2M | 0.11% |
1,209,297
-2,500
| -0.2% | -$159K |
|
208
W.W. Grainger
GWW
$61.3B
| $76M | 0.11% |
96,400
-82,200
| -46% | -$56.6M |
|
209
Cisco
CSCO
$475B
| $75.2M | 0.11% |
+1,453,105
| New | +$71.5M |
|
210
Honeywell
HON
$72.9B
| $75M | 0.11% |
383,445
-1,554,472
| -80% | -$289M |
|
211
Cal-Maine
CALM
$3.87B
| $74.5M | 0.11% |
1,655,520
+297,113
| +22% | +$14.8M |
|
212
Tencent Music
TME
$14.3B
| $74.4M | 0.11% |
10,079,090
+2,105,400
| +26% | +$15.9M |
|
213
Cosan
CSAN
$2.54B
| $73.6M | 0.11% |
4,931,082
-256,700
| -5% | -$3.33M |
|
214
Sarepta Therapeutics
SRPT
$1.92B
| $73.5M | 0.11% |
642,078
-164,400
| -20% | -$21.2M |
|
215
Coca-Cola Femsa
KOF
$23B
| $72.7M | 0.1% |
872,904
-229,500
| -21% | -$19.7M |
|
216
Nu Skin
NUS
$237M
| $72.6M | 0.1% |
2,186,596
-98,800
| -4% | -$3.64M |
|
217
O'Reilly Automotive
ORLY
$74.9B
| $72.5M | 0.1% |
1,138,410
-1,275,240
| -53% | -$77.9M |
|
218
NetApp
NTAP
$38.9B
| $72.2M | 0.1% |
944,422
-239,700
| -20% | -$16.2M |
|
219
eBay
EBAY
$47.2B
| $72M | 0.1% |
1,611,240
+480,156
| +42% | +$21.3M |
|
220
Virtu Financial
VIRT
$4.86B
| $71.7M | 0.1% |
4,197,323
-73,000
| -2% | -$1.34M |
|
221
Opendoor
OPEN
$3.48B
| $71.5M | 0.1% |
18,377,833
+6,316,663
| +52% | +$13.7M |
|
222
Nomad Foods
NOMD
$1.59B
| $71.2M | 0.1% |
4,064,679
+150,000
| +4% | +$2.73M |
|
223
Marriott International
MAR
$91.1B
| $70.3M | 0.1% |
382,716
-622,137
| -62% | -$108M |
|
224
Consolidated Edison
ED
$39.8B
| $70.2M | 0.1% |
776,864
+59,300
| +8% | +$5.67M |
|
225
Skyworks Solutions
SWKS
$10.3B
| $70M | 0.1% |
632,783
+619,900
| +4,812% | +$65.4M |
|
Similar funds
Jim Simons's Q2 2023 Portfolio in Review
As of Q2 2023, Jim Simons held 4,468 positions worth $69.4B, down 7.9% from $75.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons withdrew a net $8.1B in Q2 2023, closing 599 positions and reducing 1,691 holdings. Its most notable exit was UnitedHealth, an estimated $686M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Jim Simons opened a new position in Berkshire Hathaway Class A worth $316M.
- Jim Simons's largest Q2 2023 buy was Berkshire Hathaway Class A: 611 shares worth $316M.
- Jim Simons added most to Apple in Q2 2023, an estimated $856M increase.
- Jim Simons's biggest Q2 2023 reduction was Amazon, cutting an estimated $1.03B.
- Jim Simons fully exited UnitedHealth in Q2 2023, selling an estimated $686M.
- Jim Simons's ten largest holdings make up 12% of its $69.4B portfolio in Q2 2023.
- Jim Simons opened 541 new positions and closed 599 in Q2 2023.
- Jim Simons's portfolio value fell 7.9% quarter-over-quarter to $69.4B.
Based on Renaissance Technologies's 13F filing for Q2 2023, filed 11 Aug 2023.